Nasal high flow breathing support during exercise for COPD
Part of Lungs & breathing clinical trials.
This study tests whether a special nasal breathing device (nasal high flow) can help people with COPD exercise longer and more comfortably. It compares the device to standard low-flow oxygen or no oxygen at all.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a diagnosis of COPD
- You must be able to walk on your own (no cane, walker, or wheelchair)
- You use low-flow oxygen at 4 liters per minute or less, or no oxygen at all
- You must not be pregnant
- You must not have a pacemaker, defibrillator, or metal implants in your chest
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smart oxygen system that automatically adjusts oxygen levels for people with COPD who are in the hospital using a nasal high-flow device. It may help keep your oxygen levels stable without needing constant adjustments.
This study tests whether a home high-flow nasal breathing device (myAirvo 3) helps people with COPD who recently needed hospital care for a flare-up. You would use the device at home and track symptoms, oxygen levels, and heart rate daily to see how well it works.
This study looks at how a breathing treatment called nasal high-flow therapy affects lung function over time in people with severe chronic obstructive pulmonary disease (COPD). It may help patients understand if this therapy could be useful for managing their condition.
This study tests whether breathing high-flow oxygen through a nasal tube during exercise helps people with heart failure exercise longer and feel better. Researchers will compare how well patients do with and without this extra oxygen during cardiac rehabilitation.
This trial compares two types of breathing support you can use at home—high-flow nasal cannula (a gentle flow of warm, moist air through the nose) and noninvasive ventilation (a mask that helps push air into your lungs). The goal is to see which one works better for people with stable COPD and high carbon dioxide levels in their blood.
This trial tests whether a special type of oxygen delivered through the nose (high-flow nasal oxygen) helps people hospitalized for a COPD flare-up. It is likely meant for people with significant breathing problems and recent repeat flare-ups.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.